Abstract
With the aim to overcome the lack of potent and selective Hyaluronidases (Hyals) inhibitors, we have tested new 1, 3 and 5 substituted indole derivatives for the inhibition of bovine testicular hyaluronidases (BTH) in a stains-all assay at pH 7 and in a Morgan-Elson assay at pH 3.5. Most of the compounds are found as activator at pH 3.5. Although amine compounds 17 and 18 did not show inhibition of BTH at pH 7, they reacted as most potent activators of BTH at pH 3.5. On the other hand, some of the imine compounds reacted as the inhibitors at pH 7 and compound 25 was found as the most potent inhibitor.
Keywords: Hyaluronidase, Indole derivatives, Inhibition, Morgan-Elson assay, Stains all assay, Structure-activity, glycosaminoglycanes, HA fragments, extracellular matrix, opthalmology, lanostanoids, Vilsmeir formylation reaction, Schiff bases, Stains-all Assay
Letters in Drug Design & Discovery
Title: Structure-Activity Evaluation of N-benzyl-5-substituted Indole-3-imine Derivatives and their Amine Congeners as Bovine Testicular Hyaluronidase (BTH) Inhibitor
Volume: 8 Issue: 8
Author(s): S. Olgen, A. Kaessler, Z. Kilic Kurt and J. Jose
Affiliation:
Keywords: Hyaluronidase, Indole derivatives, Inhibition, Morgan-Elson assay, Stains all assay, Structure-activity, glycosaminoglycanes, HA fragments, extracellular matrix, opthalmology, lanostanoids, Vilsmeir formylation reaction, Schiff bases, Stains-all Assay
Abstract: With the aim to overcome the lack of potent and selective Hyaluronidases (Hyals) inhibitors, we have tested new 1, 3 and 5 substituted indole derivatives for the inhibition of bovine testicular hyaluronidases (BTH) in a stains-all assay at pH 7 and in a Morgan-Elson assay at pH 3.5. Most of the compounds are found as activator at pH 3.5. Although amine compounds 17 and 18 did not show inhibition of BTH at pH 7, they reacted as most potent activators of BTH at pH 3.5. On the other hand, some of the imine compounds reacted as the inhibitors at pH 7 and compound 25 was found as the most potent inhibitor.
Export Options
About this article
Cite this article as:
Olgen S., Kaessler A., Kurt Z. Kilic and Jose J., Structure-Activity Evaluation of N-benzyl-5-substituted Indole-3-imine Derivatives and their Amine Congeners as Bovine Testicular Hyaluronidase (BTH) Inhibitor, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576079
DOI https://dx.doi.org/10.2174/157018011796576079 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Carbon Monoxide in Kidney Function: Is a little Carbon Monoxide Good for the Kidney?
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived Compounds
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Medicinal Chemistry Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Current Drug Targets Molecular Foundations for Personalized Therapy in Prostate Cancer
Current Drug Targets Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets Regenerative Potential of Stem Cell-derived Extracellular Vesicles in Spinal Cord Injury (SCI)
Current Stem Cell Research & Therapy Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Current Cancer Drug Targets Chondroitin Sulfate and Sulfur Containing Chondroprotective Agents: Is there a Basis for their Pharmacological Action?
Current Rheumatology Reviews Editorial [Hot Topic: Cancer Vaccine and Immunotherapy (Executive Editor: Farid Saleh)]
Current Pharmaceutical Design Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression
Current Cancer Drug Targets CD40L - A Multipotent Molecule for Tumor Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry Current Strategy for Cisplatin Delivery
Current Cancer Drug Targets